PHARMABLOCK
30072536.622.29% ( +0.82 )
PHARMABLOCK (300725)
PharmaBlock Sciences (Nanjing), Inc. provides chemistry products and services throughout the pharmaceutical research and development, and commercial manufacturi...
- Open
- 35.58
- High
- 37.35
- Low
- 35.51
- Prev. Close
- 35.80
- Volume
- 133.08K
- Turnover
- 490.27M
- Avg Price
- 36.84
- Bid/Ask Ratio
- --
- Amplitude
- 5.14%
- 52wk High
- 51.19
- Volume Ratio
- 0.56
- Turnover Ratio
- 5.69%
PHARMABLOCK Analyst Rating
View MoreForecast & Rating
Feb 14, 2026Price forecast
¥47.0028.35%
Forecast & RatingBuy
1analysts
- Strong buy0.00%
- Buy100.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- prnewswire · Jul 20 at 09:58 AM
10:57 ETPharmaBlock impulsa la química verde en la fabricación farmacéutica sostenible
- PR Newswire · Jun 4 at 07:21 AM
PharmaBlock's First Peptide GMP Pilot-scale Plant at PharmaBlock Zhejiang Site Now Operational
- Zhitong · Sep 18, 2025 at 06:19 AM
PHARMABLOCK shareholder Zhou Quan plans to reduce holdings by no more than 2.3296 million shares
- Zhitong · Sep 16, 2025 at 11:21 PM
Xinjiang Communications Construction Group convertible bonds "JiaoJian Convertible Bonds" will cease trading
- Zhitong · Sep 11, 2025 at 01:19 AM
Zhejiang Merchants Securities: The growth trend of the CXO sector in 25H1 continues to improve, and the construction projects remain at a high level
- Zhitong · Sep 10, 2025 at 03:40 AM
PHARMABLOCK: PHARMABLOCK convertible bonds are about to be redeemed, reminding investors to convert their shares in a timely manner
